Main Article Content
Objective: Ureteral metastasis of prostate cancer is a very rare pathology, that can be confused with an upper urinary tract urothelial carcinoma, with great implications in the surgical management and therapy of the disease.
Case: A 56-years old male patient admitted to the emergency room with 2 weeks history of left flank pain without low urinary tract symptoms or hematuria. PSA level was 43,4 ng/ml. The patient underwent prostate needle biopsy and ureteral biopsy using flexible ureteroscopy, after the Lich-Gregoire ureterovesical reimplantation. In this case, renal colic as the first symptom of a ureteral metastasis secondary to prostate cancer is extremely rare which diagnosed in the patient.
Conclusion: Neoureterocystostomy is a safe and effective treatment for ureteral obstruction due to prostate cancer metastasis, with low morbidity and significant benefits in terms of quality of life for patients with life expectancy more than 10 years.
2. Kim HL, Puymon MR, Qin M, Guru K, Mohler JL. A method for using life tables to estimate lifetime risk for prostate cancer death. Journal of the National Comprehensive Cancer Network. 2010;8(2):148-54.
3. Gandaglia G, Abdollah F, Schiffmann J, Trudeau V, Shariat SF, Kim SP, et al. Distribution of metastatic sites in patients with prostate cancer: a population‐based analysis. The Prostate. 2014;74(2):210-6. İHG QW567890*
4. Javanmard B, Yousefi M, Yaghoobi M, Hadad AH, Amani M, Fadavi B, et al. Ureteral reimplantation or percutaneous nephrostomy: Which one is better in management of complete ureteral obstruction due to advanced prostate cancer? International Journal of Cancer Management. 2017;10(9).
5. Grigore N, Pirvut V, Mihai I, Hasegan A, Mitariu SIC. Side-Effects of Polyurethane Ureteral Stents with or without Hydrogel Coating in Urologic Pathology. Materiale Plastice. 2017;54(3):517.